|
|
 |
|
Viewing report
|
|
|
|
Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review
GlobalData, March 2012, Pages: 146
Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review
Summary
Boehringer Ingelheim GmbH (Boehringer) is a group of companies engaged in the research, development, manufacture and sale of pharmaceuticals to improve the health and quality of life. The company’s products are used in the treatment of central nervous system, respiratory, cardiovascular, urological and virological disorders. It has advanced its research in thrombo-embolic, metabolic and oncological diseases. Its research and development facilities are located at 12 sites in seven countries and operate production plants in more than 15 countries. The company carries out its operations under two reportable segments, namely, Human Pharmaceuticals and Animal Health. The company operates through 142 affiliated companies located across the world. Boehringer is headquartered in Ingelheim, Germany.
The company's strategy is to develop its products so that it can offer innovative medicines to its customers and animals. In line with its research and development strategy, the company carries out drug discovery and development across six therapeutic areas at its four major research and development sites and three smaller specialized sites. In line with its strategy to concentrate on research and development activities the company recently opened a veterinary research & development center in Zhangjiang, China.
Boehringer Ingelheim GmbH Key Recent Developments
Mar 12, 2012: Boehringer Ingelheim Sets Up First Asian Veterinary Research & Development Center In Shanghai
Feb 29, 2012: Boehringer Ingelheim Expands Capabilities In Biopharmaceutical Process Science
Feb 03, 2012: Boehringer Ingelheim, GWT And TU Dresden Sign Diabetes Research Collaboration
Feb 01, 2012: Ablynx Receives €5m Milestone Payment As Boehringer Ingelheim Selects NANOBODY Candidate For Pre-clinical Development
Jan 26, 2012: Boehringer Ingelheim Launches Lean-to-Clinic Program For Fast Drug Product Supply
GlobalData’s Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Customers who bought this item also bought
Boehringer Ingelheim GmbH - Strategy and SWOT Report
Boehringer Ingelheim GmbH Market Share Analysis
Boehringer Ingelheim GmbH - Product Pipeline Review - 2012
Boehringer Ingelheim GmbH - Strategy and SWOT Report
BSN medical GmbH - Strategic SWOT Analysis Review
Boehringer Ingelheim GmbH - SWOT Analysis
Boehringer Ingelheim GmbH - Product Pipeline Review - H2 2011
Boehringer Ingelheim GmbH - Product Pipeline Review - Q4 2010
Grunenthal GmbH - Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
|
|
|
|
